期刊
AMERICAN JOURNAL OF EPIDEMIOLOGY
卷 177, 期 12, 页码 1317-1325出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/aje/kws394
关键词
Arg72Pro; cancer; meta-analysis; rs1042522; TP53
资金
- National Institute of Research Resources [UL1 RR025752]
- Maria P. Lemos Foundation
Preferential loss of heterozygosity at the rs1042522 locus of the tumor protein 53 gene (TP53) (Arg72Pro) is observed in several tumors. Genetic association studies in oncology often use tumor tissue rather than unaffected tissue for genotyping; in such cases, loss of heterozygosity at the TP53 locus could lead to differential misclassification and could bias estimates of association. We searched multiple databases (through March 8, 2011) for studies investigating the association of Arg72Pro with breast, lung, colorectal, ovarian, or endometrial cancer. Meta-analysis was performed with multilevel Bayesian models. Informative priors for the bias effect were derived from a meta-analysis of the same polymorphism in cervical cancer. Of 160 studies (68 breast, 42 lung, 26 colorectal, 16 ovarian, and 8 endometrial cancer), 22 used tumor tissue as the source of genotyping material for cases. Use of tumor tissue versus other sources of genotyping material was associated with an apparent protective effect of the proline allele (relative odds ratio 0.78, 95 credible interval: 0.70, 0.88). The probability that use of tumor tissue induced bias was estimated to be higher than 99. Use of tumor tissue as the source of genotyping material for cases is associated with significant bias in the estimate of the genetic effect in cancer genetic association studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据